CJC-1295 DAC 5MG – Long-Acting GHRH Analog for Endocrine Research
Quantum Biogenix presents research-grade CJC-1295 DAC, a long-acting synthetic analog of Growth Hormone–Releasing Hormone (GHRH) designed for extended endocrine and metabolic research applications. This compound enables sustained investigation of growth hormone signaling, IGF-1 modulation, and hormonal regulation pathways in controlled laboratory environments.
CJC-1295 DAC incorporates a Drug Affinity Complex (DAC) that extends its biological half-life by facilitating albumin binding. This prolonged activity allows researchers to examine long-term growth hormone release patterns and downstream metabolic effects, making it a valuable tool in endocrine, metabolic, and aging-related research models.
| Product Name | CJC-1295 DAC |
| Category | GHRH Analog Research Peptide |
| Form | Lyophilized Peptide Powder |
| Purity | ≥98% HPLC Verified |
| Application | Endocrine & Hormonal Regulation Research |
| Usage | Laboratory Research Only |
Scientific Overview of CJC-1295 DAC
- Synthetic analog of Growth Hormone–Releasing Hormone (GHRH)
- Includes Drug Affinity Complex (DAC) for extended activity
- Stimulates sustained endogenous growth hormone release
- Supports investigation of IGF-1 and endocrine signaling pathways
- High-purity peptide suitable for long-term laboratory studies
Key Research Applications
- Endocrine Regulation Studies – Examination of growth hormone secretion dynamics and hormonal feedback mechanisms.
- IGF-1 Pathway Research – Investigation of insulin-like growth factor modulation and downstream metabolic effects.
- Metabolic Function Analysis – Study of growth hormone influence on lipid and glucose metabolism.
- Aging & Longevity Models – Evaluation of hormonal changes associated with aging in experimental systems.
- Protein Synthesis Research – Assessment of anabolic signaling pathways in controlled laboratory models.
Laboratory Handling & Storage
- Form: Lyophilized peptide powder
- Purity: ≥98% (HPLC verified)
- Recommended Storage: Store frozen or refrigerated, protected from moisture and light
- Handling: Reconstitute using sterile laboratory-grade solvents under aseptic conditions
- Stability: Maintain sealed and dry until research use
Mechanism of Research Interest
CJC-1295 DAC functions by binding to GHRH receptors in the pituitary, stimulating prolonged release of endogenous growth hormone. The inclusion of the Drug Affinity Complex significantly extends peptide activity, enabling sustained hormonal signaling over extended research timelines.
Experimental models demonstrate that prolonged growth hormone elevation influences IGF-1 production, metabolic regulation, and tissue maintenance pathways. These properties make CJC-1295 DAC a critical research tool for studying long-term endocrine and metabolic adaptations.
Why Choose Quantum Biogenix?
- High-purity research peptides
- Batch-tested laboratory-grade compounds
- Strict quality control and verification
- Research-focused formulation standards
- Professional laboratory supply chain handling
Research Use Only Notice
This product is supplied strictly for laboratory research use. It is not intended for human consumption, therapeutic use, or veterinary application. Researchers must adhere to institutional safety and laboratory handling regulations.
Scientific References
- Teichman S.L. et al. (2006). Prolonged stimulation of growth hormone secretion by CJC-1295. Journal of Clinical Endocrinology & Metabolism.
- Giustina A. et al. (2008). Growth hormone and IGF-1 regulation in metabolic research. Endocrine Reviews.
- Foster C.M. et al. (2010). Long-acting GHRH analogs and endocrine signaling. Molecular Endocrinology.





Reviews
There are no reviews yet.